| Literature DB >> 35734506 |
Ana Penezić1, Marija Santini1, Zdravko Heinrich1, Darko Chudy1, Pavle Miklić1, Bruno Baršić1.
Abstract
There are different options for surgical treatment of brain abscess, mainly standard craniotomy and stereotactic aspiration. It has not yet been established which of these options is associated with a more favorable outcome under similar baseline conditions of patients. Demographic characteristics, microbiology, clinical presentation, and treatment outcome were analyzed for surgically treated adult patients with brain abscess over a 14-year period. A propensity score model was applied to account for baseline conditions that may determine the choice of neurosurgical method. The propensity score was included in the prediction of a favorable outcome, defined as a Glasgow Outcome Scale (GOS) score 4 or 5. We analyzed 91 adult surgically treated patients, of which 53 had standard craniotomy and 38 stereotactic aspiration of brain abscess. Focal neurological deficit was the most common symptom present in 60 (65.9%) patients on admission. Sixty-seven (73.6%) patients had GOS 4 or 5, and seven (7.7%) patients died. The choice of surgery did not influence the outcome (OR 1.181, 95% CI 0.349-3.995), neither did the time elapsed from diagnosis to surgery (OR 0.998, 95% CI 0.981-1.015). Propensity towards standard craniotomy procedure did not influence outcome in brain abscess patients (OR 1.181, 95% CI 0.349-3.995). Worse outcome (GOS below 4) was independently associated with Glasgow Coma Score (GCS) on admission (OR 0.787, CI 0.656-0.944). The choice of neurosurgical procedure did not influence the outcome in patients with brain abscess. Patients with brain abscess who had lower GCS on admission also had worse outcome.Entities:
Keywords: Brain abscess; Craniotomy; Glasgow Outcome Scale; Stereotactic aspiration
Mesh:
Year: 2021 PMID: 35734506 PMCID: PMC9196233 DOI: 10.20471/acc.2021.60.04.01
Source DB: PubMed Journal: Acta Clin Croat ISSN: 0353-9466 Impact factor: 0.932
Fig. 1Study flow of adult brain abscess patients during the period from July 1, 2000 to July 1, 2014, treated at Dr. Fran Mihaljević University Hospital for Infectious Diseases, Zagreb, Croatia.
Basic demographic and clinical characteristics of surgically treated patients with brain abscess
| Demographic and clinical characteristics, N=91 | Neurosurgical approach | p-value | |
|---|---|---|---|
| Standard craniotomy, n=53 | Stereotactic aspiration, | ||
| Age (yrs), median (IQR)a | 44.0 (29.0-55.0) | 50.5 (32.0-60.0) | 0.273 |
| Sex, male (%)b | 40 (75.5%) | 27 (71.1%) | 0.895 |
| Chronic diseasesb: | |||
| Alcoholism | 6 (11.3%) | 6 (15.8%) | 0.774 |
| Arteriovenous malformations | 3 (5.7%) | 6 (15.8%) | 0.277 |
| Cerebral diseases | 14 (26.4%) | 9 (23.7%) | 0.974 |
| Diabetes mellitus | 2 (3.8%) | 4 (10.5%) | 0.419 |
| Cardiovascular diseases | 8 (15.1%) | 5 (13.2%) | 1.000 |
| Chronic pulmonary diseases | 7 (13.2%) | 11 (28.9%) | 0.189 |
| Hematologic malignancy | 1 (1.9%) | 3 (7.9%) | 0.403 |
| Brain abscess originb: | |||
| Otogenic infection/sinusitis | 20 (37.7%) | 4 (10.5%) | 0.013 |
| Pulmonary infection | 2 (3.8%) | 4 (10.5%) | 0.419 |
| Meningitis | 9 (17.0%) | 5 (13.2%) | 0.928 |
| Head trauma | 2 (3.8%) | 0.0% | 0.668 |
| Odontogenic foci | 2 (3.8%) | 4 (10.5%) | 0.419 |
| Skin and soft tissue infection | 1 (1.9%) | 0.0% | 1.000 |
| Origin unknown | 17 (32.1%) | 21 (55.3%) | 0.090 |
IQR = interquartile range; aKruskal-Wallis test; bFisher exact test.
Clinical presentation and brain abscess characteristics of surgically treated patients
| Neurosurgical approach | p-value | ||
|---|---|---|---|
| Standard craniotomy, n=53 | Stereotactic aspiration, | ||
| Clinical presentation: | |||
| GCS on admission, median (IQR)a | 15.0 (13.0-15.0) | 15.0 (14.0-15.0) | 0.806 |
| Seizuresb | 17 (32.1%) | 7 (18.4%) | 0.359 |
| Focal neurological signsb | 34 (64.2%) | 26 (68.4%) | 0.916 |
| Feverb | 27 (50.9%) | 24 (63.2%) | 0.535 |
| Headacheb | 36 (67.9%) | 22 (57.9%) | 0.624 |
| Meningismb | 15 (28.3%) | 10 (26.3%) | 1.000 |
| Vomitingb | 9 (17.0%) | 9 (23.7%) | 0.711 |
| Brain abscess characteristics: | |||
| Formed capsule (%)b | 45 (84.9%) | 37 (97.4%) | 0.074 |
| Multiloculated abscess (%)b | 5 (9.4%) | 0 | 0.073 |
| Multiple abscesses (%)b | 14 (26.4%) | 15 (39.5%) | 0.254 |
| Intraventricular rupture on admission (%)b | 1 (1.9%) | 6 (15.8%) | 0.020 |
| Largest diameter of the largest abscess (mm), median (IQR)a, c | 30.0 (14.5-40.0) | 30.0 (20.0-35.0) | 0.851 |
IQR = interquartile range; aMann-Whitney test; bFisher exact test; cabscess diameter was available in 78 (85.7%) study patients, i.e. 44 (75.9%) and 34 (89.5%) patients with surgical excision and aspiration, respectively.
Microbiological characteristics of patients with brain abscess
| Pathogen species | Number of isolatesa (%) |
|---|---|
| 22 (40%) | |
| 12 | |
|
| 4 |
| 3 | |
| Other | 3 |
| 4 (7.3%) | |
| Coagulase-negative staphylococcus | 4 |
| Gram-negative bacteria | 12 (21.8%) |
|
| 5 |
| 2 | |
|
| 1 |
|
| 3 |
| Other | 1 |
| Anaerobic bacteria | 16 (29.1%) |
| 7 | |
| Bacteroides | 2 |
| Fusobacterium | 2 |
| Propionibacterium | 2 |
| Other | 5 |
| Other pathogens | 4 (8.0%) |
aSome patients had more than one microbiological organism isolated.
Timing and outcome in surgically treated patients with brain abscess
| Neurosurgical approach | p-value | ||
|---|---|---|---|
| Standard craniotomy, n=53 | Stereotactic aspiration, | ||
| Timinga: | |||
| Days from disease onset to optimal therapy, median (IQR) | 12.0 (7.0-20.0) | 17.0 (8.0-33.0) | 0.084 |
| Days from disease onset to surgery, median (IQR) | 9.0 (5.0-20.0) | 16.0 (8.0-33.0) | 0.004 |
| Duration of antimicrobial treatment after surgery (days), median (IQR) | 36.0 (30.0-45.0) | 35.0 (28.0-46.0) | 0.942 |
| Total duration of antimicrobial treatment (days), median (IQR) | 43.0 (36.0-57.0) | 52.0 (42.0-63.0) | 0.122 |
| Outcome: | |||
| Favorable outcomeb,c | 41 (77.4%) | 26 (68.4%) | 0.348 |
| Mortality (%)b | 4 (7.5%) | 3 (7.9%) | 1.000 |
IQR = interquartile range; aMann-Whitney test; bFisher exact test; cfavorable outcome was defined as Glasgow Outcome Score (GOS) 4 and 5.
Comparison of patients with favorable (GOS 4 and 5) and unfavorable outcome (GOS 1 to 3) by demographic, clinical and timing features
| Unfavorable outcome (GOS 1-3), n=24 (26.4%) | Favorable outcome (GOS 4 and 5), n=67 (73.6%) | p-value | |
|---|---|---|---|
| Age in years, median (IQR)a | 54.5 (39.5-63.5) | 45.0 (28.0-55.0) | 0.111 |
| Male gender (%)b | 20 (83.3%) | 47 (70.1%) | 0.453 |
| Comorbidityb: | |||
| Diabetes mellitus | 5 (20.8%) | 1 (1.5%) | 0.009 |
| Clinical presentationa: | |||
| GCS at admission, median (IQR) | 13.0 (10.5-14.5) | 15.0 (14.0-15.0) | <0.001 |
| Timinga: | |||
| Days from disease onset to optimal therapy, median (IQR) | 21.5 (11.5-40.5) | 12.0 (6.0-21.0) | 0.008 |
| Days from disease onset to surgery, median (IQR) | 16.0 (11.0-33.0) | 10.0 (5.0-20.0) | 0.007 |
GOS = Glasgow Outcome Score; GCS = Glasgow Coma Score; IQR = interquartile range; aMann-Whitney test; bFisher exact test
Logistic regression analysis of variables that might influence the outcome: time from diagnosis to surgery (days), GCS score, type of surgery, and propensity score for standard craniotomy
| Variable | OR | 95% Wald | p-value | |
|---|---|---|---|---|
| Days from disease onset to surgery | 0.998 | 0.981 | 1.015 | 0.825 |
| GCS at admission | 0.787 | 0.656 | 0.944 | 0.010 |
| Propensity score for standard craniotomy | 0.125 | 0.011 | 1.454 | 0.097 |
GOS = Glasgow Outcome Score; GCS = Glasgow Coma Score; OR = odds ratio; favorable outcome was defined as GOS 4 or 5.
Studies that identify factors which influence outcome in patients with brain abscess
| Prognostic factor | Age | Gender | GCS | Comorbidities | Type of NRS procedure | Microbiological agents | Time aspects | Sepsis | Other factors |
|---|---|---|---|---|---|---|---|---|---|
| Takeshita, 1998 | - | - | + | - | - | - | - | - | + |
| Lu, 2002 | - | - | - | 0 | - | 0 | - | + | - |
| Kao PT, 2003 | - | - | - | - | 0 | 0 | + | 0 | - |
| Xiao, 2005 | - | - | + | + | + | - | - | - | 0 |
| Hakan, 2006 | - | - | + | - | + | - | - | 0 | + |
| Tseng, 2006 | - | + | + | - | - | + | - | + | - |
| Tonon, 2006 | - | - | + | 0 | - | - | - | - | 0 |
| Carpenter, 2007 | - | - | - | + | - | - | - | - | + |
| Ratnaike, 2011 | - | - | - | - | + | - | - | - | - |
| Helweg-Larsen, 2012 | - | - | + | + | - | - | - | - | + |
| Zhang, 2014 | - | + | - | + | - | 0 | 0 | 0 | + |
GCS = Glasgow Coma Scale; NRS = neurosurgical procedure; IVRA = intraventricular rupture of abscess; (-) non-relevant; (+) relevant; (0) not included in research